Tempus Wealth Planning LLC bought a new position in Oscar Health, Inc. (NYSE:OSCR – Free Report) during the 4th quarter, Holdings Channel reports. The fund bought 13,486 shares of the company’s stock, valued at approximately $181,000.
Several other large investors also recently modified their holdings of the business. Hennessy Advisors Inc. boosted its position in Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after acquiring an additional 3,544,300 shares in the last quarter. Westfield Capital Management Co. LP bought a new stake in Oscar Health during the 3rd quarter valued at approximately $27,452,000. JPMorgan Chase & Co. boosted its position in Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after acquiring an additional 938,742 shares in the last quarter. Soros Fund Management LLC bought a new stake in Oscar Health during the 3rd quarter valued at approximately $12,726,000. Finally, Geode Capital Management LLC boosted its position in Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after acquiring an additional 455,205 shares in the last quarter. 75.70% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now directly owns 146,036 shares in the company, valued at approximately $2,640,330.88. The trade was a 5.24 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Joshua Kushner bought 358,619 shares of the firm’s stock in a transaction on Wednesday, November 13th. The shares were bought at an average price of $13.74 per share, with a total value of $4,927,425.06. Following the completion of the purchase, the insider now owns 5,810,700 shares in the company, valued at approximately $79,839,018. The trade was a 6.58 % increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.
Oscar Health Price Performance
Oscar Health (NYSE:OSCR – Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. As a group, research analysts expect that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.
Wall Street Analyst Weigh In
OSCR has been the topic of several research reports. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $21.56.
Check Out Our Latest Stock Analysis on Oscar Health
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
- Five stocks we like better than Oscar Health
- The Role Economic Reports Play in a Successful Investment Strategy
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.